Dena Rosen Ramey

2.3k total citations
51 papers, 1.7k citations indexed

About

Dena Rosen Ramey is a scholar working on Surgery, Economics and Econometrics and Rheumatology. According to data from OpenAlex, Dena Rosen Ramey has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Economics and Econometrics and 12 papers in Rheumatology. Recurrent topics in Dena Rosen Ramey's work include Lipoproteins and Cardiovascular Health (17 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Dena Rosen Ramey is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Dena Rosen Ramey collaborates with scholars based in United States, Canada and United Kingdom. Dena Rosen Ramey's co-authors include James F. Fries, Gaurav Singh, Jean‐Pierre Raynauld, Gurkirpal Singh, Frank Kannenberg, Gerd Assmann, H.W. HULAN, F. G. PROUDFOOT, John B. Wong and James F. Fries and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Dena Rosen Ramey

49 papers receiving 1.6k citations

Peers

Countries citing papers authored by Dena Rosen Ramey

Since Specialization

Citations

This map shows the geographic impact of Dena Rosen Ramey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dena Rosen Ramey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dena Rosen Ramey more than expected).

Fields of papers citing papers by Dena Rosen Ramey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dena Rosen Ramey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dena Rosen Ramey. The network helps show where Dena Rosen Ramey may publish in the future.

Co-authorship network of co-authors of Dena Rosen Ramey

This figure shows the co-authorship network connecting the top 25 collaborators of Dena Rosen Ramey. A scholar is included among the top collaborators of Dena Rosen Ramey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dena Rosen Ramey. Dena Rosen Ramey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology, disease burden of pulmonary arterial hypertension in China: A systematic literature review 2025 ·Respiratory Medicine ·Caojin Zhang, Helen Ding, (unknown), Dena Rosen Ramey, (unknown), Zhiming Zhou, Mei Yang, Dominik Lautsch	1
2	Major Bleeding Rates in an International Cohort of Patients With End-Stage Kidney Disease 2024 ·Kidney International Reports ·Catelyn Coyle, Lori D. Bash, Dena Rosen Ramey, G. Brandon Atkins, Irina Barash, Murilo Guedes, Roberto Pecoits‐Filho, (unknown), Angelo Karaboyas, Marc P. Bonaca	0
3	Evaluation of Responder Thresholds for PAH-SYMPACT Domain Scores in Patients With Sotatercept Treatment in the STELLAR Study 2024 ·(unknown), Janethe de Oliveira Pena, F. Wang, Gregory T. Golm, Brian Miller, Dena Rosen Ramey	1
4	Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study 2022 ·Kidney Medicine ·Nicholas S. Roetker, Haifeng Guo, Dena Rosen Ramey, Ciaran J. McMullan, G. Brandon Atkins, James B. Wetmore	4
5	Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data 2022 ·BMC Pulmonary Medicine ·Tracey Weiss, Dena Rosen Ramey, Lingfeng Yang, Xinyue Liu, Mahesh J. Patel, Swapnil Rajpathak, Ednan K. Bajwa, Dominik Lautsch	1
6	Results from a cross-sectional, observational study to assess inadequate pain relief in patients with knee and/or hip osteoarthritis in Mexico 2021 ·Reumatología Clínica (English Edition) ·Rubén Burgos‐Vargas, Jyoti Aggarwal, Kelly Johnson, Dena Rosen Ramey, (unknown), Cynthia Macahilig, (unknown), Kaan Tunceli	3
7	Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey 2015 ·Lipids in Health and Disease ·Michel Krempf, Ross J. Simpson, Dena Rosen Ramey, Philippe Brudi, Hilde Giezek, Joanne E. Tomassini, Raymond Lee, Michel Farnier	15
8	Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial 2014 ·The American Journal of Cardiology ·Anders Green, Dena Rosen Ramey, Martha Emneus, Maria Iachina, Knut Stavem, Kristian Bolin, Richard McNally, Michael Busch-Sørensen, Ronnie Willenheimer, Kenneth Egstrup, Y. Antero Kesäniemi, Simon Ray, Nermine O. Basta, (unknown), Terje R. Pedersen	20
9	LDL-C Levels in US Patients at High Cardiovascular Risk Receiving Rosuvastatin Monotherapy 2014 ·Clinical Therapeutics ·Veronica Ashton, Qiaoyi Zhang, Ning Jackie Zhang, (unknown), Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, Elizabeth Marrett	4
10	Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy 2013 ·Vascular Health and Risk Management ·JoAnne M. Foody, Peter P. Tóth, Shiva Sajjan, Dena Rosen Ramey, (unknown), Andrew M. Tershakovec, (unknown), Henry Hu, Joanne E. Tomassini	32
11	Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting 2013 ·Journal of clinical lipidology ·Ross J. Simpson, Kaan Tunceli, Dena Rosen Ramey, David Neff, David M. Kern, Hui‐Min Hsieh, Debra Wertz, Judith J. Stephenson, Elizabeth Marrett, Joanne E. Tomassini, Terry A. Jacobson	24
12	Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction 2011 ·Journal of clinical lipidology ·Peter P. Tóth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, Xiaohan Hu, Kaan Tunceli	16
13	LOSS OF EARLY GAINS IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENT AMONG HIGH RISK PATIENTS 2010 ·Journal of the American College of Cardiology ·JoAnne M. Foody, Shiva Sajjan, Henry Hu, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, Joanne E. Tomassini, Kaan Tunceli	2
14	Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients 2010 ·Journal of clinical lipidology ·Kaan Tunceli, Shiva G. Sajjan, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, Xiaohan Hu, Joanne E. Tomassini, JoAnne M. Foody	14
15	Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension 2007 ·Current Medical Research and Opinion ·Alan Morrison, Dena Rosen Ramey, Janet van Adelsberg, Douglas J. Watson	46
16	The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis 2005 ·Current Medical Research and Opinion ·Dena Rosen Ramey, Douglas J. Watson, Chang Yu, James A. Bolognese, Sean Curtis, Alise Reicin	59
17	Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: Results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study 2005 ·Nutrition Metabolism and Cardiovascular Diseases ·Gerd Assmann, Paul Cullen, John R. Erbey, Dena Rosen Ramey, Frank Kannenberg, H. Schulte	195
18	Long-term morbidity, mortality, and economics of rheumatoid arthritis 2001 ·Arthritis & Rheumatism ·John B. Wong, Dena Rosen Ramey, Gurkirpal Singh	107
19	Comparative toxicity of non-steroidal anti-inflammatory agents 1994 ·Pharmacology & Therapeutics ·Gurkirpal Singh, Dena Rosen Ramey, (unknown), James F. Fries	45
20	The relative toxicity of disease‐modifying antirheumatic drugs 1993 ·Arthritis & Rheumatism ·James F. Fries, Catherine A. Williams, Dena Rosen Ramey, D. Blöch	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact